Literature DB >> 17591847

Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species.

Analy S Melo1, Arnaldo L Colombo, Beth A Arthington-Skaggs.   

Abstract

The paradoxical growth (PG) of Candida sp. biofilms in the presence of high caspofungin (CAS) concentrations was previously unknown. We sought to characterize the PG at supra-MICs of CAS among clinical Candida sp. isolates grown as biofilms in 96-well polystyrene microtiter plates. The MICs of CAS were determined for 30 clinical Candida sp. isolates (4 Candida albicans, 6 C. tropicalis, 7 C. parapsilosis, 8 C. orthopsilosis, and 5 C. metapsilosis isolates) when they were grown as planktonic cells and biofilms and were defined as the lowest drug concentrations that resulted in a prominent decrease in growth and a 50% reduction in metabolic activity, respectively. PG was defined as a resurgence of growth (>50% of that in the drug-free growth control well) at drug concentrations above the MIC. With the exception of C. tropicalis, all isolates displayed PG more frequently when they were grown as biofilms than when they grown as planktonic cells. PG was undetectable among C. metapsilosis isolates in planktonic cell MIC tests but was present in 100% of the isolates in biofilm MIC tests. The drug concentration and the number of drug dilutions supporting PG were higher for biofilms than for planktonic cells. Microscopic changes in cell morphology were observed among both planktonic and biofilm cells with PG. Specifically, the accumulation of enlarged, globose cells was associated with PG, and we hypothesize that CAS-induced changes in the cell wall composition may be the explanation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591847      PMCID: PMC2043224          DOI: 10.1128/AAC.00676-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

Review 1.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Clin Infect Dis       Date:  2001-04-03       Impact factor: 9.079

2.  Should vascular catheters be removed from all patients with candidemia? An evidence-based review.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2002-01-24       Impact factor: 9.079

Review 3.  Candida biofilms: antifungal resistance and emerging therapeutic options.

Authors:  Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Curr Opin Investig Drugs       Date:  2004-02

4.  Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces.

Authors:  D M Kuhn; J Chandra; P K Mukherjee; M A Ghannoum
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents.

Authors:  G S Baillie; L J Douglas
Journal:  J Antimicrob Chemother       Date:  2000-09       Impact factor: 5.790

6.  Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Authors:  D M Kuhn; T George; J Chandra; P K Mukherjee; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 7.  Biofilms: survival mechanisms of clinically relevant microorganisms.

Authors:  Rodney M Donlan; J William Costerton
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

Review 8.  Caspofungin: the first representative of a new antifungal class.

Authors:  Valérie Letscher-Bru; Raoul Herbrecht
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

9.  Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection.

Authors:  Y Jin; H K Yip; Y H Samaranayake; J Y Yau; L P Samaranayake
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

Review 10.  Biofilms: microbial life on surfaces.

Authors:  Rodney M Donlan
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

View more
  35 in total

1.  In vitro assessment of the antifungal and paradoxical activity of different echinocandins against Candida tropicalis biofilms.

Authors:  Tsun Sheng N Ku; Stella M Bernardo; Samuel A Lee
Journal:  J Med Microbiol       Date:  2011-06-23       Impact factor: 2.472

2.  Cranberry-derived proanthocyanidins prevent formation of Candida albicans biofilms in artificial urine through biofilm- and adherence-specific mechanisms.

Authors:  Hallie S Rane; Stella M Bernardo; Amy B Howell; Samuel A Lee
Journal:  J Antimicrob Chemother       Date:  2013-10-10       Impact factor: 5.790

3.  Structure-activity relationship study of the plant-derived decapeptide OSIP108 inhibiting Candida albicans biofilm formation.

Authors:  Nicolas Delattin; Katrijn De Brucker; David J Craik; Olivier Cheneval; Barbara De Coninck; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

4.  Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms.

Authors:  Gordon Ramage; Anto Jose; Leighann Sherry; David F Lappin; Brian Jones; Craig Williams
Journal:  Antimicrob Agents Chemother       Date:  2013-02-19       Impact factor: 5.191

5.  Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Authors:  Maria Simitsopoulou; Pavla Peshkova; Efthymia Tasina; Aspasia Katragkou; Daniela Kyrpitzi; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

6.  Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.

Authors:  A Gomez-Lopez; A Alastruey-Izquierdo; D Rodriguez; B Almirante; A Pahissa; J L Rodriguez-Tudela; M Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

7.  In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.

Authors:  Kwan Soo Ko; Ji-Young Lee; Jae-Hoon Song; Kyong Ran Peck
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

8.  Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates.

Authors:  Carla J Walraven; Stella M Bernardo; Nathan P Wiederhold; Samuel A Lee
Journal:  Med Mycol       Date:  2013-12-22       Impact factor: 4.076

9.  Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.

Authors:  Cristina Rueda; Manuel Cuenca-Estrella; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

10.  Fungal echinocandin resistance.

Authors:  Louise A Walker; Neil A R Gow; Carol A Munro
Journal:  Fungal Genet Biol       Date:  2009-09-19       Impact factor: 3.495

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.